Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020

Autor: Paratore, C., Zichi, C., Audisio, M., Bungaro, M., Caglio, A., Di Liello, R., Gamba, T., Gargiulo, P., Mariniello, A., Reale, M.L., Perrone, F., Di Maio, M.

Publikováno v: In ESMO Open December 2022 7(6)

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.

Autor: Rossi A; Unit of Precision Medicine in Breast Cancer, Department of Gynaecological Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Aimar G; Division of Medical Oncology, Santa Croce e Carle Hospital, Cuneo, Italy; Department of Oncology, University of Turin, Italy., Audisio M; Department of Oncology, ASL TO4, Ivrea Community Hospital, Ivrea (TO), Italy., Bungaro M; Medical Oncology, Ospedale Michele e Pietro Ferrero, Verduno (CN), Italy., Caglio A; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Di Liello R; UOC Oncologia, P.O. Ospedale del Mare, ASL Napoli 1, Naples, Italy., Gamba T; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Gargiulo P; Clinical Trial Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Ghisoni E; Department of Oncology, Immuno-Oncology Service, University Hospital of Lausanne (UNIL-CHUV), Lausanne, Switzerland., Lombardi P; Phase 1 Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Marandino L; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mariniello A; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA; Department of Oncology, University of Turin, San Luigi Gonzaga University Hospital, Orbassano (TO), Italy., Paratore C; Department of Oncology, ASL TO4, Ivrea Community Hospital, Ivrea (TO), Italy., Reale ML; Medical Oncology Unit, Vito Fazzi Hospital, Lecce, Italy., Trastu F; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Tuninetti V; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy., Turco F; Department of Oncology, University of Turin, San Luigi Gonzaga University Hospital, Orbassano (TO), Italy; IOSI (Oncology Institute of Southern Switzerland), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Fabi A; Unit of Precision Medicine in Breast Cancer, Department of Gynaecological Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Perrone F; Clinical Trial Unit, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Di Maio M; Department of Oncology, University of Turin, Ordine Mauriziano Hospital, Turin, Italy. Electronic address: massimo.dimaio@unito.it.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Aug; Vol. 189, pp. 112920. Date of Electronic Publication: 2023 May 15.

471P Liver toxicities during cyclin-dependent kinase inhibitors (CDKi) in patients affected by hormone receptor-positive breast cancer (BC)

Autor: Paratore, C., Audisio, M., Bombaci, S., Bungaro, M., Dionisio, R., Ferrari, G., Gaudino, E., Grassi, L., Hotca, A., Loddo, C., Manuguerra, G., Manzin, E., Novello, S., Numico, G., Persano, I., Sculli, C., Sperone, P., Valsecchi, A.A., Zucchini, G., Vellani, G.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S379-S379

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study.

Autor: Angusti T; Unit of Nuclear Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., DI Stefano RF; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Parente A; Unit of Nuclear Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Bungaro M; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Turco F; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Samuelly A; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Pisano C; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., Scagliotti GV; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy., DI Maio M; Division of Medical Oncology, Department of Oncology, Ordine Mauriziano Hospital, University of Turin, Turin, Italy., Tucci M; Division of Medical Oncology, Department of Oncology, Cardinal Massaia Hospital, Asti, Italy - marcello.tucci@gmail.com., Buttigliero C; Division of Medical Oncology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.

Publikováno v: Minerva urology and nephrology [Minerva Urol Nephrol] 2022 Dec; Vol. 74 (6), pp. 703-713. Date of Electronic Publication: 2022 Feb 11.

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer.

Autor: Mariniello A; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.; Department of Immunology and Microbiology, Emory University School of Medicine, Atlanta, GA 30322, USA., Tabbò F; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Indellicati D; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Tesauro M; Immuno-Pathology Unit, Mauriziano Umberto I Hospital, 10128 Torino, Italy., Rezmives NA; Immuno-Pathology Unit, Mauriziano Umberto I Hospital, 10128 Torino, Italy., Reale ML; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Listì A; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Capelletto E; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Carnio S; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Bertaglia V; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Mecca C; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Consito L; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., De Filippis M; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Bungaro M; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Paratore C; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Di Maio M; Department of Oncology, University of Torino at Mauriziano Umbero I Hospital, 10128 Torino, Italy., Passiglia F; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Righi L; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Sangiolo D; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.; Laboratory of Experimental Cell Therapy Candiolo Cancer Institute FPO-IRCCS, 10060 Torino, Italy., Novello S; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy., Geuna M; Immuno-Pathology Unit, Mauriziano Umberto I Hospital, 10128 Torino, Italy., Bironzo P; Department of Oncology, University of Torino at San Luigi Gonzaga Hospital, 10043 Orbassano, Italy.

Publikováno v: Cells [Cells] 2022 Oct 14; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 14.